A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 187 500 KRW 0.27% Market Closed
Market Cap: 10.3T KRW

Wall Street
Price Targets

Price Targets Summary
ABL Bio Inc

Wall Street analysts forecast ABL Bio Inc stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABL Bio Inc is 151 980 KRW with a low forecast of 77 770 KRW and a high forecast of 220 500 KRW.

Lowest
Price Target
77 770 KRW
59% Downside
Average
Price Target
151 980 KRW
19% Downside
Highest
Price Target
220 500 KRW
18% Upside
ABL Bio Inc Competitors:
Price Targets
KALV
Kalvista Pharmaceuticals Inc
100% Upside
GILD
Gilead Sciences Inc
8% Upside
NTLA
Intellia Therapeutics Inc
131% Upside
MNKD
MannKind Corp
56% Upside
ADMA
ADMA Biologics Inc
34% Upside
ARGX
argenx SE
16% Upside
ATRA
Atara Biotherapeutics Inc
14% Upside
IVA
Inventiva SA
224% Upside

Revenue
Forecast

Revenue Estimate
ABL Bio Inc

For the last 7 years the compound annual growth rate for ABL Bio Inc's revenue is 141%. The projected CAGR for the next 3 years is 50%.

141%
Past Growth
50%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
ABL Bio Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
ABL Bio Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABL Bio Inc's stock price target?
Price Target
151 980 KRW

According to Wall Street analysts, the average 1-year price target for ABL Bio Inc is 151 980 KRW with a low forecast of 77 770 KRW and a high forecast of 220 500 KRW.

What is ABL Bio Inc's Revenue forecast?
Projected CAGR
50%

For the last 7 years the compound annual growth rate for ABL Bio Inc's revenue is 141%. The projected CAGR for the next 3 years is 50%.

Back to Top